Drug Description in Trials / DrugBank / KEGG DRUG
Search results
No. | DrugBank | Drug (Description in trials) | KEGG DRUG | KEGG GENES | KEGG PATHWAY | Disease ID |
---|---|---|---|---|---|---|
1 | Deucravacitinib | [1] Deucravacitinib Deucravacitinib | [1] Deucravacitinib
Deucravacitinib
💬
| [1] TYK2 TYK2 💬
| [17] Coronavirus disease - COVID-19 Coronavirus disease - COVID-19, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis 💬 | [9] 36 36, 37, 49, 53, 84, 96, 97, 160, 269 💬
|